Abstract: Background. Definitive radiotherapy (RT) for head and neck cancer is increasingly used to preserve organ function, whereas surgery is reserved for treatment failure. However, data are sparse regarding the feasibility of salvage surgery, particularly for unselected patients after accelerated RT.
In head and neck squamous cell carcinomas (HNSCCs), radiotherapy (RT) with or without chemotherapy is increasingly used to preserve organ function, with surgery held as a second-line treatment modality for salvage of locoregional failures. This treatment strategy has been shown to be effective in selected patients, particularly for laryngeal 1 and hypopharyngeal carcinoma 2 -5 or isolated neck recurrence. 6 On the other hand, altered RT fractionation schedules, either used alone or combined with chemotherapy, have become a frequently prescribed treatment option in advanced HNSCC. 7 In our experience, however, salvage surgery is uncommonly performed in this setting, despite the potential for increasing ultimate cure rates. The literature provides little insight into the proportion of failures amenable to salvage surgery, 8 the value of salvage surgery, 9 or the reasons surgical management of recurrences is not attempted.
Since 1991, we have routinely treated patients with HNSCC with accelerated RT by use of a concomitant boost technique. 10 This study was undertaken to analyze how patients whose accelerated RT was unsuccessful were managed, with a special emphasis on factors influencing the decision for salvage surgery and the associated morbidity.
PATIENTS AND METHODS
Patient Characteristics. From February 1991 to June 2001, 297 patients were treated with radical accelerated RT with or without chemotherapy. Pretreatment evaluation consisted of medical history and physical examination, panendoscopy, chest x-ray, and CT or MRI of the head and neck region. The characteristics of patients seen with local or regional failure are detailed in Table 1 .
Therapy and Follow-up. The RT schedule has been described previously. 10 The planned total dose was 69.9 Gy delivered in 41 fractions over 38 days. A technique combining lateral opposing 6-MV beams to the primary tumor and the cervical lymph nodes and a single anterior field to the supraclavicular and inferior neck nodes was used in most cases. Chemotherapy (usually cisplatin with or without 5-fluorouracil) was administered in 97 patients (33%) initially seen generally with T3 to T4 or N2 to N3 tumors; of these patients, 82 (85%) had at least one cycle concomitantly with RT. Forty-two patients (14%) underwent a neck dissection before RT, but no patients had primary surgical treatment of the primary tumor or a planned neck dissection after radiotherapy. Patients were scheduled to have a monthly clinical examination for the first 2 years and every 2 to 4 months thereafter without a planned routine imaging, except for patients enrolled in prospective trials.
Statistical Analysis. The chi-square test (twotailed) and Fisher exact test were used to evaluate differences in proportions, whereas the log-rank test was used to compare survival curves. The actuarial overall survival rate was calculated with the Kaplan-Meier method, and the Cox regression model was used for multi- Table 1 . Characteristics of patients with local and/or regional failure (n = 75).
Characteristic
All patients (n = 75) 
RESULTS
Seventy-five patients (25%) had local and/or regional failure. Fifty-nine patients had both local and regional recurrence, 12 had neck metastasis, and four had primary tumor recurrence only. Included in this analysis are 12 patients (16%) initially seen with disease persistence, defined as disease progression occurring within 3 months of the end of RT. Seventeen patients (23%) had salvage surgery. The mean time from the end of RT to salvage surgery was 16 months (range, 3.3 -53.4 months). Seven patients had palliative chemotherapy only, and one patient had RT and chemotherapy. Besides patients initially seen with locoregional recurrences, 25 patients were initially seen with distant metastasis alone. Thus, for all patients, the actuarial disease-free survival (DFS) rate was 61% at 5 years.
Factors Correlated with Treatment Decision. Table 1 compares the characteristics of patients undergoing salvage surgery with those of patients for whom surgical treatment was not carried out. Although all patients with recurrent laryngeal cancers (five of five) were operated on (all had N1 disease and three had T1 disease), salvage surgery was attempted in only 16% to 20% of patients with the other tumor locations ( p = .001).
Moreover, patients with low T and N classifications at the time of the initial diagnosis were more likely to have salvage surgery ( p = .002 and .014, respectively). There was no difference between the two groups in terms of initial performance status, sex, and age. (n = 55) of patients who had no salvage surgery died from their cancer, only 60% (n = 10) of patients who had surgery died from their cancer. The corresponding 3-year post-recurrence overall actuarial survival rates were 16% and 46%, respectively, and 53% (n = 9) of patients who underwent surgery were free of disease at last follow-up or death.
In a univariate analysis, T classification ( p = .0021), surgery ( p = .005, Figure 1) , and the Union Internationale Contre le Cancer (UICC) stage ( p = .0061) were significant factors influencing overall survival. Chemotherapy ( p = .25), World Health Organization (WHO) performance status ( p = .26), N classification ( p = .25), and sex ( p = .85) were all not significant. In a multivariate analysis including the preceding significant factors, only the UICC stage retained its significance ( p = .035), whereas surgery was of borderline significance ( p = .063). Because of small sample size, all analyses are considered exploratory only, and appropriate caution must be taken in interpreting results.
Complications of Salvage Surgery. Of 17 patients operated on, 13 patients were initially seen with one or more complications, whereas four had none ( Table 3 ). The most frequently encountered complications were related to neck wound healing or its subsequent leakage, as well as fistula formation. Moreover, one patient died from a hemorrhage after composite resection.
DISCUSSION
Radical RT with or without chemotherapy is a well-established primary treatment for head and neck cancers. Implicit in the acceptance of this treatment approach is the potential availability of radical surgery as second-line therapy for locoregional failures. However, there are few studies addressing the feasibility of salvage operations in unselected patients treated with the more aggressive nonsurgical treatment schedules and few data to shed light on the reasons why only a minority of patients are able to undergo surgical salvage.
The feasibility of salvage surgery depends on not only the location of the recurrence but also its extent and the type of surgery that can be attempted. Previous studies reported that the proportion of patients eligible for salvage surgery ranged between 34% and 75%, with patients with laryngeal cancers being the most often and most successfully salvaged. 3 -5,11 -13 In our series, all patients with laryngeal recurrences were operated on, whereas less than one quarter of the patients with recurrences in other locations were able to have salvage surgery. Although in some reports salvage surgery in patients with glottic carcinoma has been reported to yield an ultimate tumor control of more than 80%, 4 in our series, locoregional disease progression remained the main cause of death. In line with the literature finding, in our series most patients who were not selected for surgical salvage either were initially seen with disease that was judged too extensive or were medically inoperable because of poor general condition. Other authors predominantly reported concurrent metastatic disease, patient refusal, 11, 12 and unresectable disease 6, 11 as reasons for not having surgery. Although patients with initially potentially operable cancers are often offered the choice between either surgery or RT, it would be of interest to know to what extent potentially operable patients remain eligible for surgery at the time of recurrence. In our series, only 54% of patients initially seen with stage I to II disease underwent salvage surgery, suggesting that the latter option became nonfeasible in many patients who were initially operable. However, the limitations of retrospective analyses preclude any definitive conclusion on this issue. Nevertheless, studies assessing the value of early recurrence detection with the different imaging tools should be encouraged, particularly for patients with initially resectable disease.
Acute and late toxicity are increased in accelerated RT regimens and concurrent chemotherapy, but both increase local control and overall survival when compared with standard regimens or radiotherapy alone. 7,14 -16 Toxicity of the primary treatment might well be an important factor in the treatment decision for a recurrence. Compared with monofractionated RT schedules, increased toxicity might be more likely to render patients medically unfit for surgery or might more often lead to an unwillingness of patients to undergo further treatment. In fact, little is known about the influence of the type of RT fractionation on operability and rate of surgical complications. It has been reported 17 that, after hyperfractionated accelerated RT, surgery becomes increasingly less difficult with increasing interval after RT. It is thought that the main surgical problem after RT is impaired healing because of disturbances in perfusion of irradiated tissue. But for most altered fractionated schemes, no higher incidence of surgical complications has been reported. From a randomized study, Davidson et al 11 compared the results of salvage surgery between patients treated with either a hyperfractionated or a hypofractionated RT schedule. Surgical complications were identical in both groups (27%). Generally, the rate of complication was higher when surgery was performed for the primary tumor or combined with neck dissection and lower when only a neck dissection was done. Parsons et al 12 did not find a higher surgical complication rate (37%) when comparing once-daily with twice-daily RT for supraglottic laryngeal cancer, whereas Johansen et al 4 reported a higher incidence of fistula after split-course RT.
In conclusion, in an unselected population treated with accelerated concomitant boost RT, with the exception of laryngeal cancers, salvage surgery is uncommonly used, because most patients are medically unfit or have extensive recurrences. In centers where nonsurgical approaches are favored for treatment of patients with initially resectable disease, an intensive and effective follow-up is needed to detect recurrences as early as possible to optimize the potential benefits of salvage surgery.
